<DOC>
	<DOCNO>NCT00006300</DOCNO>
	<brief_summary>The purpose study threefold : 1 ) evaluate prevalence risk oral complication patient aplastic anemia ; 2 ) evaluate oral problem patient predict response treatment ; 3 ) review complication dental treatment patient order establish treatment guideline . This study perform review medical chart 79 patient aplastic anemia 67 patient schizophrenia treat National Institutes Health Dental Clinic 1993 1999 . The schizophrenia patient serve control population . Demographic , clinical radiographic information collect patient . Additional data collect aplastic anemia patient include medical therapy , disease duration , blood cell count , oral problem develop treatment treatment response .</brief_summary>
	<brief_title>Oral Manifestations Aplastic Anemia</brief_title>
	<detailed_description>The prevalence , risk factor significance oral manifestation aplastic anemia well characterize . Thus , present study , retrospective chart review , document prevalence oral complication AA patient risk oral manifestation case-control study . Schizophrenic patient represent control . Information include following ; demographic , clinical radiographic information case control . Additional data collection AA patient include prior medical therapy , CBC differential , disease duration , new oral manifestation AA treatment medical treatment response . We determine systemic clinical feature AA predict oral manifestation , oral manifestation predict treatment outcome AA patient . Finally complication follow dental treatment compile review establish initial treatment guideline patient .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Oral Manifestations</mesh_term>
	<criteria>INCLUSION CRITERIA : Cases : All aplastic anemia patient evaluate NIH dental clinic consultation 19931999 . Controls : All schizophrenic patient evaluate NIH dental clinic consultation 19931999 . EXCLUSION CRITERIA : Patients without diagnosis aplastic anemia case schizophrenia control .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2002</verification_date>
	<keyword>Immunosuppression</keyword>
	<keyword>Treatment Recommendations</keyword>
	<keyword>Pancytopenia</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Inpatient Population</keyword>
</DOC>